All In Biotech

Drug Trial Radar · NCT01255839

The Balloon Project for Birth Induction

A Prospective Multi-centre Randomised Comparison on Induction of Labour With Double-balloon Installation Device Versus Prostaglandin E2 Minprostin

Last checked: Nov 20, 2026Latest source record: Dec 8, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 825 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

825

Actual

Start

Dec 2002

Primary completion

Sep 2005

Study completion Dec 2010

Sponsor

Lead sponsor
Glostrup University Hospital, CopenhagenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 8, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The use of prostaglandin E2 (PGE2) for induction of labour in women with unfavourable cervices is well-established1. There are, however, potential side effects to prostaglandins, in particular the risk of uterine hypertonicity which may affect fetal outcome. In theory a mechanical ripening based on dilatation of the cervix as well as induction of production of endogenous prostaglandin has potentially less influence on the fetal outcome but a Cochrane review from 2001 scrutinized studies on mechanical ripening versus placebo/no treatment or prostaglandin E2. They conclude there is insufficient data to evaluate the effectiveness in terms of likelihood of vaginal delivery in 24 hours, and emphasise the need for large sample size studies and substantive outcomes. Two later randomised studies compared mechanical ripening to PGE2 and found discrepant results regarding time from induction to delivery. The primary purpose of the present study was in a randomized design to compare the efficacy of double-balloon catheter versus vaginal PGE2 (minprostin 3 mg) on induction of labour, duration of birth and fetal outcome. Secondary analyses were to evaluate the results for various subgroups, i.e. primipara/multipara, gemelli, vaginal birth after caesarean, preterm birth and intra uterine growth restriction.

Conditions

  • Induction Time
  • Apgar Score
  • Admission to Neonatal Unit
  • Vaginal Delivery
  • Caesarean Section

Interventions

  • Double BalloonDevice

    The Double Balloon Catheter was applied (Atad 5) with 80 ml NaCl installed intrauterine above the intern orificium and 80 ml below in cervix/vagina.

  • MinprostinDrug

    The prostaglandin 2 minprostin (3mg) was applied vaginally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. success of induction of labour, duration of birth and fetal outcomeTime frame: at birth

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Glostrup University Hospital

    Glostrup Municipality, Glostrup, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.